Article
Author(s):
Bethesda, MD-A combination of low-dose bacille Calmette-Guin and interferon-alpha (IFN-a) has shown promise in the treatment of bladder cancer patients who have failed initial treatment with BCG.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.